Reference21 articles.
1. Davies LM, Drummond MF (1993) Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. Br J Psychiatry 162:38–42
2. Essock SM, Hargreaves WA, Covell NH, Goethe J (1996) Clozapine’s effectiveness for patients in state hospitals: Results from a randomized trial. Psychopharmacol Bull 32:683–697
3. Essock SM, Hargreaves WA, Dohm FA, Goethe J, Carver L, Hipshman L (1996) Clozapine eligibility among state hospital patients. Schizophr Bull 22:15–25
4. Freeman HL (1997) Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: Three efficacy studies. Int Clin Psychopharmacol 12: S11–S17
5. Hamilton SH, Revicki DA, Genduso LA, Besley CM (1998) Olanzapine versus placebo and haloperidol: Quality of life and efficacy results of the North American double-blind trial. Neuropsychopharmacology 18: 41–49
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献